Tag: Lixiana

The results of the safety profile and efficacy of Lixiana study

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban

The first patient has been enrolled into Daiichi Sankyo’s ENTRUST-AF PCI study. The multinational, randomised phase 3b study will evaluate a treatment regimen based...